Skip to main content

Table 9 The concentration of HGF level in stroke patients with and without vascular risk factors

From: Paradoxical role of hepatocyte growth factor in ischemic stroke: stroke risk/stroke recovery

Stroke patients (N = 100) HGF Concentration (ng/ml) U test P value
X ± SD Range
Hypertensive (N = 67) 0.59 ± 0.14 0.4–0.85 6.24 < 0.001*
Non-hypertensive (N = 33) 0.37 ± 0.17 0.15–0.82
Diabetic (N = 67) 0.62 ± 0.17 0.23–0.85 6.24 < 0.001*
Non-diabetics (N = 33) 0.40 ± 0.11 0.15–0.54
Smoker (N = 32) 0.72 ± 0.07 0.60–0.85 7.83 < 0.001*
Non-smoker (N = 68) 0.42 ± 0.12 0.15–0.82
Dyslipidemic (N = 48) 0.61 ± 0.18 0.43 ± 0.12 5.07 < 0.001*
Non-dyslipidemic (N = 52) 0.17–0.83 0.15–0.85
Obese (N = 59) 0.60 ± 0.15 0.23–0.83 5.90 < 0.001*
Non-obese (N = 41) 0.39 ± 0.13 0.15–0.82
  1. X mean, SD standard deviation, U Mann–Whitney U test, *highly significant, HGF hepatocyte growth factor